Jim Cramer Calls Kimberly-Clark a Hated Dividend King. Is He Right?
Jim Cramer called Kimberly-Clark a 'dividend king' with a high yield, despite recent underperformance. The company has a 54-year dividend growth streak but faces challenges like revenue misses and operational issues. Its acquisition of Kenvue adds uncertainty. Recent positive developments include better-than-expected Q3 guidance and regulatory approvals. The stock is up 10.11% year-to-date, with a yield of about 4.8%.
How this was made
The 30-second read
Why it matters
The trading relevance is mainly about dividend durability and cash-flow coverage versus near-term earnings momentum and easing deal/regulatory uncertainty.
Market read
For KMB, the article’s actionable angle is whether investors will discount the dividend due to free-cash-flow coverage near parity, or re-rate on improving earnings and deal progress.
What to watch
The article emphasizes cash coverage but does not quantify how much of the capex ramp is expected to reverse, nor does it detail potential cost savings from the transformation that could restore coverage.
Background
Jim Cramer’s commentary frames Kimberly-Clark as a “hated dividend king,” and the article tests that thesis using dividend math, free-cash-flow coverage, and recent operational and deal-related developments.
Ticker impact
Article discusses Kimberly-Clark’s dividend “king” status while highlighting weak free-cash-flow coverage and recent operational headwinds, plus the pending Kenvue acquisition uncertainty.
Likely choppy trading as investors weigh dividend durability and cash-flow pressure against improving near-term fundamentals and deal-completion catalysts.
The piece is primarily an editorial framing, but it cites concrete cash coverage (dividends vs free cash flow) and specific catalysts (preliminary Q3 beat, regulatory approvals, EPS decline guidance) that can influence positioning.
Market effects
Highlights typical consumer staples dividend-grower risk: cash-flow coverage can matter more than EPS when capex and transformation spending rise.
No direct regional market shock beyond China diaper disinformation impact and European/Brazil regulatory steps tied to the Kenvue deal.
Deal-related regulatory approvals and China demand noise are relevant to global staples sentiment, but the article is not a broad macro catalyst.
Counterpoint
Investors may look through near-term free-cash-flow pressure as transformation capex peaks, focusing instead on the company’s consecutive EPS estimate beats and margin expansion.
Key entities
- companyKimberly-Clark
Dividend grower discussed for dividend sustainability, cash-flow coverage, and uncertainty around the pending Kenvue acquisition.
- companyKenvue
Target in Kimberly-Clark’s pending acquisition, with regulatory approvals and conditions mentioned.
- mediaCNBC
Source of Cramer’s on-air commentary and related reporting referenced in the article.
